chr6-24806366-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001286445.3(RIPOR2):c.*7G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.506 in 1,524,680 control chromosomes in the GnomAD database, including 200,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 16113 hom., cov: 32)
Exomes 𝑓: 0.51 ( 184296 hom. )
Consequence
RIPOR2
NM_001286445.3 3_prime_UTR
NM_001286445.3 3_prime_UTR
Scores
2
Splicing: ADA: 0.01401
2
Clinical Significance
Conservation
PhyloP100: -0.390
Genes affected
RIPOR2 (HGNC:13872): (RHO family interacting cell polarization regulator 2) This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 6-24806366-C-T is Benign according to our data. Variant chr6-24806366-C-T is described in ClinVar as [Benign]. Clinvar id is 517548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPOR2 | NM_001286445.3 | c.*7G>A | 3_prime_UTR_variant | 22/22 | ENST00000643898.2 | NP_001273374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPOR2 | ENST00000643898.2 | c.*7G>A | 3_prime_UTR_variant | 22/22 | NM_001286445.3 | ENSP00000494268 | A2 | |||
RIPOR2 | ENST00000259698.9 | c.*7G>A | 3_prime_UTR_variant | 23/23 | 1 | ENSP00000259698 | A2 | |||
RIPOR2 | ENST00000538035.6 | c.*7G>A | 3_prime_UTR_variant | 22/22 | 2 | ENSP00000441138 | A2 | |||
RIPOR2 | ENST00000613507.4 | c.*7G>A | 3_prime_UTR_variant | 23/23 | 5 | ENSP00000482957 | A2 |
Frequencies
GnomAD3 genomes AF: 0.447 AC: 67887AN: 151832Hom.: 16113 Cov.: 32
GnomAD3 genomes
AF:
AC:
67887
AN:
151832
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.465 AC: 72494AN: 155784Hom.: 17748 AF XY: 0.469 AC XY: 38739AN XY: 82556
GnomAD3 exomes
AF:
AC:
72494
AN:
155784
Hom.:
AF XY:
AC XY:
38739
AN XY:
82556
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.512 AC: 703348AN: 1372730Hom.: 184296 Cov.: 24 AF XY: 0.512 AC XY: 347178AN XY: 678548
GnomAD4 exome
AF:
AC:
703348
AN:
1372730
Hom.:
Cov.:
24
AF XY:
AC XY:
347178
AN XY:
678548
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.447 AC: 67923AN: 151950Hom.: 16113 Cov.: 32 AF XY: 0.446 AC XY: 33136AN XY: 74264
GnomAD4 genome
AF:
AC:
67923
AN:
151950
Hom.:
Cov.:
32
AF XY:
AC XY:
33136
AN XY:
74264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1037
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | c.*7G>A in exon 23 of FAM65B: This variant is not expected to have clinical sign ificance because it has been identified in 52.33% (4623/8834) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs9358799). - |
Autosomal recessive nonsyndromic hearing loss 104 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at